U.S. officials see the deal as a threat to NATO, for which Turkey provides the second-largest military.World Politicsread more
Google's services have been blocked in China for several years, but the company still has a business there, as the tech giant seeks to sell products to Chinese firms in...Technologyread more
China may have signaled it's going more hard-line on trade, but it could be a good thing, former U.S. negotiator Clete Willems told CNBC.World Economyread more
Facebook's cryptocurrency project has already been met with skepticism from policymakers around the world.Technologyread more
As China's economic growth declines, some analysts say Beijing may have to spend more on infrastructure, adding to concerns about high debts.China Economyread more
After years of speculation, Neuralink, the brain-machine interface start-up co-founded by Elon Musk, started talking directly to the public on Tuesday.Technologyread more
United's Optum is launching a new partnership with John Muir Health aimed at helping the small northern California hospital operator become more competitive with its larger...Health and Scienceread more
"The charts, as interpreted by Carley Garner, suggest that the upside in the stock market has gotten more limited," Jim Cramer says.Mad Money with Jim Cramerread more
John Paul Stevens, who served on the Supreme Court for nearly 35 years and became its leading liberal, has died.Politicsread more
Aarti Borkar from IBM Security says artificial intelligence bias can exist at three levels: the program, the data and the people who design those AI systems.Cybersecurityread more
A key read on the industry, the Architecture Billings Index, fell into negative territory in June, according to the American Institute for Architects. Inquiries for new...Real Estateread more
Former FDA commissioner Robert Califf is in talks with Alphabet's life sciences arm Verily for a leadership role, according to several people familiar with the matter. (Update: Califf announced the news on Verily's blog on Wednesday.)
Califf has been spotted at the company's South San Francisco offices, said one person. The details of the position are still being worked out, and the talks could fall through, but Califf, a legendary cardiologist, is expected to take a joint role at Stanford and Verily.
Califf would join shortly after the launch of Verily's baseline study, a well-funded effort headed up by fellow cardiologist Jessica Mega to study human health by tracking 10,000 people over at least 4 years.
Both Stanford Medicine and Duke University, where Califf is currently on leave as a tenured cardiologist, have been named as partners in that study.
The appointment of Califf would be a big win for Verily, and couldn't come at a better time. The company just lost its top academic, former National Institute of Mental Health chief Tom Insel. Insel was the latest in a series of high-profile departures from Alphabet, Google's parent company, which also includes Nest's Tony Fadell, GV's Bill Maris, and Google Fiber chief Craig Barratt.
Califf was nominated for the FDA role by President Barack Obama and stepped down in January of this year, a standard procedure with a new administration. Shortly after stepping down, he spoke out in an interview about the antiquated ways in which companies collect medical data to test new drugs and medical devices. He suggested that clinical trials should look more like A/B comparison tests routinely done by tech companies, such as Google.
It's not typical for health agency chiefs to join technology companies, but it might increasingly be an option as Silicon Valley starts moving into regulated industries. Verily works closely with life sciences companies — including Dexcom,
Watch: Dr. Califf offers advice to his successor at FDA